Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct

Fig. 1

The migration and proliferation potential of A549 cells was inhibited as Sox2 was down regulated. a The expression of Sox2 at protein level in A549 cells was analysed using western blot after transfection. shScr, A549 cells transfected with shScr. shSox2, A549 cells transfected with shSox2. The quantification assay of WB results was shown as mean ± SD obtained from three repeated experiments. ** P < 0.01 vs shScr group. b The migration capability of A549 cells was reduced after transfected with shSox2. Original magnification × 200. The quantification data shown was mean ± SD obtained from three fields. ** P < 0.01 vs shScr group. c The colony forming capability of A549 cells was inhibited after transfected with shSox2. Original magnification × 200. The quantification data shown was mean ± SD obtained from three fields. * P < 0.05 vs shScr group

Back to article page